Le Lézard
Classified in: Science and technology
Subject: FVT

Unisys CEO to Participate in J.P. Morgan Global Technology, Media and Communications Conference


BLUE BELL, Pa., May 3, 2024 /PRNewswire/ -- Unisys (NYSE: UIS) announces that the company's Chair and CEO, Peter Altabef, will participate in the J.P. Morgan Technology, Media and Communications Conference on Wednesday, May 22, 2024 at the Westin Boston Seaport District in Boston, MA. Peter will be available throughout the day for one-on-one and small group meetings. Investors that would like to schedule a meeting with Unisys should contact their J.P. Morgan representative.

About Unisys 

Unisys is a global technology solutions company that powers breakthroughs for the world's leading organizations. Our solutions ? cloud, data and AI, digital workplace, logistics and enterprise computing ? help our clients challenge the status quo and unlock their full potential. To learn how we have been helping clients push what's possible for 150 years, visit?unisys.com and follow us on LinkedIn.

RELEASE NO.: 0502/9946

Unisys and other Unisys products and services mentioned herein, as well as their respective logos, are trademarks or registered trademarks of Unisys Corporation. Any other brand or product referenced herein is acknowledged to be a trademark or registered trademark of its respective holder.

UIS-C

SOURCE Unisys Corporation


These press releases may also interest you

at 17:20
New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines' ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health awarded Panda Health Partner status for its Orchestral Health Intelligence Platform
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital's Technology Fund I Recognized as Top Performing VC Fund in the Preqin League Tables
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

More news about Science and technology...


News published on and distributed by: